<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" id="inlinetable1" position="anchor"><table frame="hsides" rules="groups"><thead><tr><th valign="top">Experiment/figure number</th><th valign="top">Statistics</th></tr></thead><tbody><tr><td valign="top"><xref ref-type="fig" rid="fig5">Figure 5B</xref>: Limb size for stage 46 DMSO&#160;or&#160;SU5402 treatments</td><td valign="top">Unpaired one-tailed Student&#8217;s t-test <break/>&#8226; n&#160;=&#160;5 (DMSO), n&#160;=&#160;6 (SU5402) <break/>&#8226; Mean (DMSO)&#160;=&#160;0.1614, Mean (SU5402)&#160;=&#160;0.072 <break/>&#8226; SD (DMSO)&#160;=&#160;0.015582, SD (SU5402)&#160;=&#160;0.0177539 <break/>&#8226; SEM (DMSO)&#160;=&#160;0.006969, SEM (SU5402)&#160;=&#160;0.007248 <break/>&#8226; p-value&lt;0.0001 <break/>&#8226; <italic>T</italic>&#160;=&#160;&#8722;8.775 <break/>&#8226; 95% confidence interval&#160;=&#160;&#8722;0.06636 to &#8722;0.11244</td></tr><tr><td valign="top"><xref ref-type="fig" rid="fig5">Figure 5E</xref>: qRT-PCR data for DMSO&#160;or&#160;SU5402 treated stage 46 limbs</td><td valign="top">Unpaired two-tailed Student&#8217;s t-test <break/>&#8226; n&#160;=&#160;3 (DMSO), n&#160;=&#160;3 (SU5402) <break/>&#8226; Mean (DMSO)&#160;=&#160;1.09 (<italic>Etv1</italic>), 1 (<italic>Etv4</italic>), 0.97 (<italic>Shh</italic>), 0.85 (<italic>Ptch1</italic>), 1.1 (<italic>Gremlin1</italic>) <break/>&#8226; Mean (SU5402)&#160;=&#160;0.28 (<italic>Etv1</italic>), 0.4 (<italic>Etv4</italic>), 0.37 (<italic>Shh</italic>), 1.25 (<italic>Ptch1</italic>), 0.47 (<italic>Gremlin1</italic>) <break/>&#8226; SD (DMSO)&#160;=&#160;0.055 (<italic>Etv1</italic>), 0.1 (<italic>Etv4</italic>), 0.06 (<italic>Shh</italic>), 0.18 (<italic>Ptch1</italic>), 0.07 (<italic>Gremlin1</italic>) <break/>&#8226; SD (SU5402)&#160;=&#160;0.05 (<italic>Etv1</italic>),. 04 (<italic>Etv4</italic>), 0.12 (<italic>Shh</italic>), 0.22 (<italic>Ptch1</italic>), 0.24 (<italic>Gremlin1</italic>) <break/>&#8226; SEM (DMSO)&#160;=&#160;0.03 (<italic>Etv1</italic>),. 06 (<italic>Etv4</italic>), 0.03 (<italic>Shh</italic>), 0.11 (<italic>Ptch1</italic>), 0.04 (<italic>Gremlin1</italic>) <break/>&#8226; SEM (SU5402)&#160;=&#160;0.03 (<italic>Etv1</italic>),. 02 (<italic>Etv4</italic>), 0.08 (<italic>Shh</italic>), 0.13 (<italic>Ptch1</italic>), 0.14 (<italic>Gremlin1</italic>) <break/>&#8226; p-value=&lt;0.0001 (<italic>Etv1</italic>), 0.0006 (<italic>Etv4</italic>), 0.0022 (<italic>Shh</italic>), 0.07 (<italic>Ptch1</italic>), 0.014 (<italic>Gremlin1</italic>) <break/>&#8226; <italic>T</italic>&#160;=&#160;&#8722;19.13 (<italic>Etv1</italic>), &#8722;9.79 (<italic>Etv4</italic>), &#8722;6.95 (<italic>Shh</italic>), 2.44 (<italic>Ptch1</italic>), &#8722;4.14 (<italic>Gremlin1</italic>) <break/>&#8226; 95% confidence interval&#160;=&#160;&#8722;0.7 to &#8722;0.91 (<italic>Etv1</italic>),&#8722;0.43 to &#8722;0.77 (<italic>Etv4</italic>), &#8722;0.36 to &#8722;0.83 (<italic>Shh</italic>), 0.9 to &#8722;0.05 (<italic>Ptch1</italic>), &#8722;0.2 to &#8722;1 (<italic>Gremlin1</italic>)</td></tr><tr><td valign="top"><xref ref-type="fig" rid="fig5">Figure 5I</xref>: Cell proliferation in DMSO or SU5402&#160;treated&#160;stage&#160;46&#160;limbs</td><td valign="top">One-way ANOVA (Kruskal-Wallis tests) <break/>&#8226; n&#160;=&#160;3 each for DMSO and SU5402 <break/>&#8226; Median: DMSO&#160;=&#160;29.15, SU5402&#160;=&#160;4.75 <break/>&#8226; p-value=0.0495</td></tr><tr><td valign="top"><xref ref-type="fig" rid="fig5s1">Figure 5&#8212;figure supplement 1A and C</xref>: Limb size for stage 45 DMSO&#160;or&#160;SU5402 and ethanol&#160;or&#160;cyclopamine treatments</td><td valign="top">Unpaired one-tailed Student&#8217;s t-test <break/>&#8226; n&#160;=&#160;15 (DMSO), n&#160;=&#160;15 (SU5402) <break/>&#8226; Mean (DMSO)&#160;=&#160;0.082, Mean (SU5402)&#160;=&#160;0.074 <break/>&#8226; SD (DMSO)&#160;=&#160;0.016, SD (SU5402)&#160;=&#160;0.012 <break/>&#8226; SEM (DMSO)&#160;=&#160;0.004, SEM (SU5402)&#160;=&#160;0.003 <break/>&#8226; p-value=0.0514 <break/>&#8226; <italic>T</italic>&#160;=&#160;&#8722;1.68637 <break/>&#8226; 95% confidence interval&#160;=&#160;&#8722;0.019 to 0.002 <break/>&#8226; n&#160;=&#160;6 (ethanol), n&#160;=&#160;6 (cyclopamine) <break/>&#8226; Mean (ethanol)&#160;=&#160;0.071, Mean (cyclopamine)&#160;=&#160;0.063 <break/>&#8226; SD (ethanol)&#160;=&#160;0.012, SD (cyclopamine)&#160;=&#160;0.006 <break/>&#8226; SEM (ethanol)&#160;=&#160;0.002, SEM (cyclopamine)&#160;=&#160;0.005 <break/>&#8226; p-value=0.909 <break/>&#8226; <italic>T</italic>&#160;=&#160;1.43 <break/>&#8226; 95% confidence interval&#160;=&#160;&#8722;0.004 to 0.02</td></tr><tr><td valign="top"><xref ref-type="fig" rid="fig5s1">Figure 5&#8212;figure supplement 1B and D</xref>: Snout to tail-tip length for DMSO&#160;or&#160;SU5402 and ethanol&#160;or&#160;cyclopamine treatments</td><td valign="top">Unpaired one-tailed Student&#8217;s t-test <break/>&#8226; n&#160;=&#160;5 (DMSO), n&#160;=&#160;6 (SU5402) <break/>&#8226; Mean (DMSO)&#160;=&#160;10.92, Mean (SU5402)&#160;=&#160;10.29 <break/>&#8226; SD (DMSO)&#160;=&#160;0.2, SD (SU5402)&#160;=&#160;0.25 <break/>&#8226; SEM (DMSO)&#160;=&#160;0.088, SEM (SU5402)&#160;=&#160;0.104 <break/>&#8226; p-value&lt;0.0007 <break/>&#8226; <italic>T</italic>&#160;=&#160;&#8722;4.5 <break/>&#8226; 95% confidence interval&#160;=&#160;&#8722;0.316 to &#8722;0.950 <break/>&#8226; n&#160;=&#160;6 (ethanol), n&#160;=&#160;6 (cyclopamine) <break/>&#8226; Mean (ethanol)&#160;=&#160;10.5, Mean (cyclopamine)&#160;=&#160;9.98 <break/>&#8226; SD (ethanol)&#160;=&#160;0.15, SD (cyclopamine)&#160;=&#160;0.3 <break/>&#8226; SEM (ethanol)&#160;=&#160;0.06, SEM (cyclopamine)&#160;=&#160;0.121 <break/>&#8226; p-value&lt;0.0016 <break/>&#8226; <italic>T</italic>&#160;=&#160;3.87 <break/>&#8226; 95% confidence interval&#160;=&#160;0.82 to 0.222</td></tr><tr><td valign="top"><xref ref-type="fig" rid="fig6">Figure 6B</xref>: Limb size for stage 46 ethanol&#160;or&#160;cyclopamine treatments</td><td valign="top">Unpaired one-tailed Student&#8217;s t-test <break/>&#8226; n&#160;=&#160;6 (ethanol), n&#160;=&#160;6 (cyclopamine) <break/>&#8226; Mean (ethanol)&#160;=&#160;0.16, Mean (cyclopamine)&#160;=&#160;0.095 <break/>&#8226; SD (ethanol)&#160;=&#160;0.008, SD (cyclopamine)&#160;=&#160;0.016 <break/>&#8226; SEM (ethanol)&#160;=&#160;0.003, SEM (cyclopamine)&#160;=&#160;0.006 <break/>&#8226; p-value&lt;0.0001 <break/>&#8226; <italic>T</italic>&#160;=&#160;8.36 <break/>&#8226; 95% confidence interval&#160;=&#160;0.08 to 0.045</td></tr><tr><td valign="top"><xref ref-type="fig" rid="fig6">Figure 6C</xref>: qRT-PCR data for ethanol&#160;or&#160;cyclopamine treated stage 46 limbs</td><td valign="top">Unpaired one-tailed Student&#8217;s t-test <break/>&#8226; n&#160;=&#160;3 (ethanol), n&#160;=&#160;3 (cyclopamine) <break/>&#8226; Mean (ethanol)&#160;=&#160;1.12 (<italic>Ptch1</italic>), 0.94 (<italic>Gremlin1</italic>), 1.12 (<italic>Fgf8</italic>) <break/>&#8226; Mean (cyclopamine)&#160;=&#160;0.7 (<italic>Ptch1</italic>), 0.39 (<italic>Gremlin1</italic>), 0.22 (<italic>Fgf8</italic>) <break/>&#8226; SD (ethanol)&#160;=&#160;0.145 (<italic>Ptch1</italic>), 0.12 (<italic>Gremlin1</italic>), 0.14 (<italic>Fgf8</italic>) <break/>&#8226; SD (cyclopamine)&#160;=&#160;0.00.04 (<italic>Ptch1</italic>), 0.1 (<italic>Gremlin1</italic>), 0.03 (<italic>Fgf8</italic>) <break/>&#8226; SEM (ethanol)&#160;=&#160;0.08 (<italic>Ptch1</italic>), 0.07 (<italic>Gremlin1</italic>), 0.08 (<italic>Fgf8</italic>) <break/>&#8226; SEM (cyclopamine)&#160;=&#160;0.02 (<italic>Ptch1</italic>), 0.06 (<italic>Gremlin1</italic>), 0.02 (<italic>Fgf8</italic>) <break/>&#8226; p-value=0.0039 (<italic>Ptch1</italic>), 0.002 (<italic>Gremlin1</italic>), 0.0002 (<italic>Fgf8</italic>) <break/>&#8226; <italic>T</italic>&#160;=&#160;4.9 (<italic>Ptch1</italic>), 5.97 (<italic>Gremlin1</italic>), 11.21 (<italic>Fgf8</italic>) <break/>&#8226; 95% confidence interval&#160;=&#160;0.66 to 0.19 (<italic>Ptch1</italic>), 0.8 to 0.3 (<italic>Gremlin1</italic>), 1.1 to 0.68 (<italic>Fgf8</italic>)</td></tr><tr><td valign="top"><xref ref-type="fig" rid="fig6">Figure 6G</xref>: Cell proliferation in ethanol or cyclopmaine treated stage&#160;46&#160;limbs</td><td valign="top">One-way ANOVA (Kruskal-Wallis tests) <break/>&#8226; n&#160;=&#160;3 each for ethanol and cyclopamine <break/>&#8226; Median: ethanol&#160;=&#160;30.06, cyclopamine&#160;=&#160;13.9, <break/>&#8226; p-value=0.0495</td></tr></tbody></table></table-wrap>